4//SEC Filing
Regulus Therapeutics Inc. 4
Accession 0001209191-16-096064
CIK 0001505512operating
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:17 PM ET
Size
5.4 KB
Accession
0001209191-16-096064
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-02-04+265,000→ 265,000 totalExercise: $6.35Exp: 2026-02-03→ Common Stock (265,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on January 1, 2017 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on January 1, 2020.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001505512
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:17 PM ET
- Size
- 5.4 KB